Science Explorer Back to mapMap
Discussion
Company · Coralville · United States

Viewpoint Molecular Targeting (United States)

viewpointmt.comROR OpenAlex
Research works
8
▲ 49% vs 2018-21
Citations
77
9.9 per fractional work
Top-10% rate
11.1%
all institutions 10.0%
Open access
38%
world 40%
International
36%
world 18%
Viewpoint Molecular Targeting (United States)

Not ranked overall: Viewpoint Molecular Targeting (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Viewpoint Molecular Targeting (United States) work in?

In all years, 75% of research at Viewpoint Molecular Targeting (United States) is in Health Sciences, 15% in Life Sciences. Its largest fields are Medicine (72%), Biochemistry, Genetics and Molecular Biology (8%), Immunology and Microbiology (7%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 6 fractional works · 74.6% of its workMedicine: 6 fractional works · 72.1% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 45.6% of its workOncology: 1 fractional works · 10.1% of its workPulmonary and Respiratory Medicine: 1 fractional works · 9.1% of its workEpidemiology: 0 fractional works · 3.7% of its workNeurology: 0 fractional works · 2.8% of its workPathology and Forensic Medicine: 0 fractional works · 0.9% of its workNursing: 0 fractional works · 2.6% of its workNutrition and Dietetics: 0 fractional works · 2.6% of its workLife Sciences: 1 fractional works · 15.0% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 7.8% of its workMolecular Biology: 0 fractional works · 5.6% of its workBiotechnology: 0 fractional works · 2.2% of its workImmunology and Microbiology: 1 fractional works · 7.2% of its workImmunology: 1 fractional works · 7.2% of its workPhysical Sciences: 1 fractional works · 10.4% of its workPhysics and Astronomy: 0 fractional works · 5.1% of its workRadiation: 0 fractional works · 5.1% of its workMaterials Science: 0 fractional works · 3.1% of its workBiomaterials: 0 fractional works · 1.5% of its workMaterials Chemistry: 0 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 0 fractional works · 2.2% of its workBiomedical Engineering: 0 fractional works · 2.2% of its workALL ITS WORKViewpointMolecular…8fractional works, all years
Life Sciences15%Physical Sciences10%Health Sciences75%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 7 fields, with their numbers
    1. Medicine672.1%
    2. Nursing02.6%
    1. Biochemistry, Genetics and Molecular Biology17.8%
    2. Immunology and Microbiology17.2%
    1. Physics and Astronomy05.1%
    2. Materials Science03.1%
    3. Engineering02.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Viewpoint Molecular Targeting (United States)?

Ranked on the quality score, Edwin A. Sagastume lead among researchers whose main affiliation is Viewpoint Molecular Targeting (United States).

  1. 1 Edwin A. Sagastume United States · #1,546,005 worldwide 273 citations · 16 works
All ranked researchers at Viewpoint Molecular Targeting (United States)

What are the most cited papers from Viewpoint Molecular Targeting (United States)?

The most cited paper from Viewpoint Molecular Targeting (United States) is "203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer" (Mengshi Li, Edwin A. Sagastume, Dongyoul Lee et al., 2020), with 57 citations. Next come "Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma" (56) and "Automated cassette-based production of high specific activity [203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer" (50).

Most cited papers
#PaperReleasedCitations
1 203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer Mengshi Li, Edwin A. Sagastume, Dongyoul Lee et al. · Current Medicinal Chemistry Open access 26 Aug 2020 57
2 Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma Mengshi Li, Dijie Liu, Dongyoul Lee et al. · Cancers Open access 22 Jul 2021 56
3 Automated cassette-based production of high specific activity [203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer Mengshi Li, Xiuli Zhang, Thomas P. Quinn et al. · Applied Radiation and Isotopes Open access 10 May 2017 50
4 Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for 203Pb and 212Pb-Based Theranostics Mengshi Li, Nicholas J. Baumhover, Dijie Liu et al. · Pharmaceutics Open access 26 Jan 2023 46
5 Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma Mengshi Li, Dijie Liu, Dongyoul Lee et al. · Molecular Pharmaceutics Open access 18 Jul 2019 32
All 19 most cited papers, with filters and sorting

Which research topics does Viewpoint Molecular Targeting (United States) publish most on?

By volume in 2022-now: Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Neuroendocrine Tumor Research Advances and Medical Imaging and Pathology Studies.

Radiopharmaceutical Chem…1Radiopharmaceutical Chemistry and Applications: 1 fractional worksMedical Imaging Techniqu…1Medical Imaging Techniques and Applications: 1 fractional worksNeuroendocrine Tumor Research Advances: 0 fractional worksMedical Imaging and Pathology Studies: 0 fractional worksCancer Research and Treatments: 0 fractional worksVitamin C and Antioxidants Research: 0 fractional worksNeuroblastoma Research and Treatments: 0 fractional worksRadiation Therapy and Dosimetry: 0 fractional worksNuclear Physics and Applications: 0 fractional worksBoron Compounds in Chemistry: 0 fractional works
Radiology, Nuclear Medicine and ImagingEpidemiologyPulmonary and Respiratory MedicineBiotechnology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Neuroendocrine Tumor Research Advances Epidemiology 0 works
  4. 4 Medical Imaging and Pathology Studies Pulmonary and Respiratory Medicine 0 works
  5. 5 Cancer Research and Treatments Biotechnology 0 works
  6. 6 Vitamin C and Antioxidants Research Nutrition and Dietetics 0 works
  7. 7 Neuroblastoma Research and Treatments Neurology 0 works
  8. 8 Radiation Therapy and Dosimetry Pulmonary and Respiratory Medicine 0 works
  9. 9 Nuclear Physics and Applications Radiation 0 works
  10. 10 Boron Compounds in Chemistry Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.5%not open62.5%

World: 40% of research is openly available.

with international co-authors35.6%domestic only64.4%

World: 18% is written across borders.

How has Viewpoint Molecular Targeting (United States)'s research output changed?

Output in 2022-2025 was 49% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Coralville

All research institutions in Coralville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Viewpoint Molecular Targeting (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.